213 related articles for article (PubMed ID: 26347605)
1. Tissue-type plasminogen activator is a neuroprotectant in the central nervous system.
Yepes M
Front Cell Neurosci; 2015; 9():304. PubMed ID: 26347605
[TBL] [Abstract][Full Text] [Related]
2. Tissue-type plasminogen activator regulates the neuronal uptake of glucose in the ischemic brain.
Wu F; Wu J; Nicholson AD; Echeverry R; Haile WB; Catano M; An J; Lee AK; Duong D; Dammer EB; Seyfried NT; Tong FC; Votaw JR; Medcalf RL; Yepes M
J Neurosci; 2012 Jul; 32(29):9848-58. PubMed ID: 22815500
[TBL] [Abstract][Full Text] [Related]
3. Tissue-type plasminogen activator mediates neuroglial coupling in the central nervous system.
An J; Haile WB; Wu F; Torre E; Yepes M
Neuroscience; 2014 Jan; 257():41-8. PubMed ID: 24200922
[TBL] [Abstract][Full Text] [Related]
4. Tissue-type plasminogen activator and the low-density lipoprotein receptor-related protein mediate cerebral ischemia-induced nuclear factor-kappaB pathway activation.
Zhang X; Polavarapu R; She H; Mao Z; Yepes M
Am J Pathol; 2007 Oct; 171(4):1281-90. PubMed ID: 17717150
[TBL] [Abstract][Full Text] [Related]
5. The low-density lipoprotein receptor-related protein 1 mediates tissue-type plasminogen activator-induced microglial activation in the ischemic brain.
Zhang C; An J; Strickland DK; Yepes M
Am J Pathol; 2009 Feb; 174(2):586-94. PubMed ID: 19147818
[TBL] [Abstract][Full Text] [Related]
6. Tissue-type plasminogen activator mediates neuronal detection and adaptation to metabolic stress.
Wu F; Nicholson AD; Haile WB; Torre E; An J; Chen C; Lee AK; Duong DM; Dammer EB; Seyfried NT; Tong FC; Votaw JR; Yepes M
J Cereb Blood Flow Metab; 2013 Nov; 33(11):1761-9. PubMed ID: 23881246
[TBL] [Abstract][Full Text] [Related]
7. Fibrinolytic and Non-fibrinolytic Roles of Tissue-type Plasminogen Activator in the Ischemic Brain.
Yepes M
Neuroscience; 2024 Mar; 542():69-80. PubMed ID: 37574107
[TBL] [Abstract][Full Text] [Related]
8. Tissue-type plasminogen activator protects neurons from excitotoxin-induced cell death via activation of the ERK1/2-CREB-ATF3 signaling pathway.
Wu F; Echeverry R; Wu J; An J; Haile WB; Cooper DS; Catano M; Yepes M
Mol Cell Neurosci; 2013 Jan; 52():9-19. PubMed ID: 23063501
[TBL] [Abstract][Full Text] [Related]
9. Tissue-type plasminogen activator has a neuroprotective effect in the ischemic brain mediated by neuronal TNF-α.
Haile WB; Wu J; Echeverry R; Wu F; An J; Yepes M
J Cereb Blood Flow Metab; 2012 Jan; 32(1):57-69. PubMed ID: 21792242
[TBL] [Abstract][Full Text] [Related]
10. Tissue-type plasminogen activator-mediated shedding of astrocytic low-density lipoprotein receptor-related protein increases the permeability of the neurovascular unit.
Polavarapu R; Gongora MC; Yi H; Ranganthan S; Lawrence DA; Strickland D; Yepes M
Blood; 2007 Apr; 109(8):3270-8. PubMed ID: 17170123
[TBL] [Abstract][Full Text] [Related]
11. Tissue-type plasminogen activator induces synaptic vesicle endocytosis in cerebral cortical neurons.
Yepes M; Wu F; Torre E; Cuellar-Giraldo D; Jia D; Cheng L
Neuroscience; 2016 Apr; 319():69-78. PubMed ID: 26820595
[TBL] [Abstract][Full Text] [Related]
12. Tissue-type Plasminogen Activator (tPA) Modulates the Postsynaptic Response of Cerebral Cortical Neurons to the Presynaptic Release of Glutamate.
Jeanneret V; Wu F; Merino P; Torre E; Diaz A; Cheng L; Yepes M
Front Mol Neurosci; 2016; 9():121. PubMed ID: 27881952
[TBL] [Abstract][Full Text] [Related]
13. New functions for an old enzyme: nonhemostatic roles for tissue-type plasminogen activator in the central nervous system.
Yepes M; Lawrence DA
Exp Biol Med (Maywood); 2004 Dec; 229(11):1097-104. PubMed ID: 15564435
[TBL] [Abstract][Full Text] [Related]
14. Conformations of tissue plasminogen activator (tPA) orchestrate neuronal survival by a crosstalk between EGFR and NMDAR.
Bertrand T; Lesept F; Chevilley A; Lenoir S; Aimable M; Briens A; Hommet Y; Bardou I; Parcq J; Vivien D
Cell Death Dis; 2015 Oct; 6(10):e1924. PubMed ID: 26469972
[TBL] [Abstract][Full Text] [Related]
15. Tissue-type plasminogen activator is a homeostatic regulator of synaptic function in the central nervous system.
Jeanneret V; Yepes M
Neural Regen Res; 2017 Mar; 12(3):362-365. PubMed ID: 28469640
[TBL] [Abstract][Full Text] [Related]
16. Role of the ubiquitin-proteasome system in brain ischemia: friend or foe?
Caldeira MV; Salazar IL; Curcio M; Canzoniero LM; Duarte CB
Prog Neurobiol; 2014 Jan; 112():50-69. PubMed ID: 24157661
[TBL] [Abstract][Full Text] [Related]
17. Elevation of mRNA levels of tissue-type plasminogen activator and urokinase-type plasminogen activator in hippocampus and cerebral cortex following middle cerebral artery occlusion in rats.
Ito T; Takenaka K; Sakai H; Yoshimura S; Hayashi K; Noda S; Sakai N
Neurol Res; 2000 Jun; 22(4):413-9. PubMed ID: 10874693
[TBL] [Abstract][Full Text] [Related]
18. Microglial low-density lipoprotein receptor-related protein 1 mediates the effect of tissue-type plasminogen activator on matrix metalloproteinase-9 activity in the ischemic brain.
Zhang C; An J; Haile WB; Echeverry R; Strickland DK; Yepes M
J Cereb Blood Flow Metab; 2009 Dec; 29(12):1946-54. PubMed ID: 19672275
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant treatment with neuroserpin increases the therapeutic window for tissue-type plasminogen activator administration in a rat model of embolic stroke.
Zhang Z; Zhang L; Yepes M; Jiang Q; Li Q; Arniego P; Coleman TA; Lawrence DA; Chopp M
Circulation; 2002 Aug; 106(6):740-5. PubMed ID: 12163437
[TBL] [Abstract][Full Text] [Related]
20. Biphasic regulation of tissue plasminogen activator activity in ischemic rat brain and in cultured neural cells: essential role of astrocyte-derived plasminogen activator inhibitor-1.
Kim JW; Lee SH; Ko HM; Kwon KJ; Cho KS; Choi CS; Park JH; Kim HY; Lee J; Han SH; Ignarro LJ; Cheong JH; Kim WK; Shin CY
Neurochem Int; 2011 Feb; 58(3):423-33. PubMed ID: 21193004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
